CS logo
small CS logo
New Jersey Regenerative Institute

Cedar Knolls, New Jersey, United States
Pain management physician in Hanover, New Jersey
197 Ridgedale Ave #210, Cedar Knolls, NJ 07927

About New Jersey Regenerative Institute


"Drs. Malanga, Bowen and Agesen of New Jersey Regenerative Institute specialize in non-surgical treatments of sports, spine and musculoskeletal issues with the highest quality regenerative cellular procedures (called "stem cell" by some). Their focus is on pain relief caused by orthopedic problems (arthritis, tendon problems [rotator cuff tears, tennis elbow], carpal tunnel, meniscus tears, knee/shoulder pain) by evaluating the patient's lifestyle, environment and underlying factors. With platelet rich plasma (PRP), adipose/Lipogems, or bone marrow, our physicians continue to have excellent results on a variety of patients who wished to avoid surgical procedures like knee and hip replacements/arthroscopy and carpal tunnel release surgery."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
GID BIO, Inc.
1
Kessler Foundation
1
Personalized Stem Cells, Inc.
1
Seikagaku Corporation
1
Total Rows: 4

Clinical Trials at New Jersey Regenerative Institute


During the past decade, New Jersey Regenerative Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11111100110000000000Started TrialsCompleted Trails2018201920202021202200.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)
2018-05-30
2023-03-01
Active, not recruiting
320
Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis
2019-09-07
2021-01-01
Unknown status
125
Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis
2020-10-15
2023-11-30
Recruiting
124
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
2022-10-13
2024-10-01
Recruiting
30

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "New Jersey Regenerative Institute" #1 collaborator was "New Jersey Regenerative Institute, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGID BIO, Inc.: 1GID BIO, Inc.: 1Kessler Foundation: 1Kessler Foundation: 1Personalized Stem Cells, Inc.: 1Personalized Stem Cells, Inc.: 1Seikagaku Corporation: 1Seikagaku Corporation: 1

Created with Highcharts 11.1.0Top CollaboratorsNew JerseyRegenerative Institute,LLC: 1New JerseyRegenerative Institute,LLC: 1

Clinical Trials Conditions at New Jersey Regenerative Institute


According to Clinical.Site data, the most researched conditions in "New Jersey Regenerative Institute" are "Knee Osteoarthritis" (2 trials), "Bone Marrow Edema" (1 trials), "Knee Pain Chronic" (1 trials), "Lumbar Disc Herniation" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "New Jersey Regenerative Institute" in a lesser frequency.

Clinical Trials Intervention Types at New Jersey Regenerative Institute


Most popular intervention types in "New Jersey Regenerative Institute" are "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Focused extracorporeal shockwave therapy" (1 trials), "GID SVF-2 Device System" (1 trials), "PSC-01" (1 trials), "SI-6603" (1 trials) and "Sham injection" (1 trials). Other intervention names were less common.

Clinical Trials Genders at New Jersey Regenerative Institute


The vast majority of trials in "New Jersey Regenerative Institute" are 4 trials for "All" genders.

Clinical Trials Status at New Jersey Regenerative Institute


Currently, there are NaN active trials in "New Jersey Regenerative Institute". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in New Jersey Regenerative Institute, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in New Jersey Regenerative Institute, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 2Not Applicable: 2Phase 1: 1Phase 1: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1Unknown status: 1Unknown status: 1